BioCentury
ARTICLE | Finance

Runway in China

Shenogen's $20M C round could get cancer company to China IPO

August 5, 2013 7:00 AM UTC

With $20 million in hand from its recent series C round, Shenogen Pharma Group Ltd. hopes it can stretch the cash to both go public and get its lead program to market in China.

The round was co-led by new investors Legend Capital and Qiming Weichuang Venture Capital. Existing investors Shenzhen Venture; China Investment Wealth Venture Fund; IDG Venture; and Lapam Venture also participated. Investors received warrants to purchase an additional $10 million of stock...